The impact of projected increases in obesity prevalence on incident liver disease in the UK: Insights from Bayesian-network modelling-Reference-Cited by-同舟云学术

The impact of projected increases in obesity prevalence on incident liver disease in the UK: Insights from Bayesian-network modelling

Published:2023-05-12 Issue: Volume: Page:
ISSN:
Container-title:2023 the 7th International Conference on Medical and Health Informatics (ICMHI)
language:
Short-container-title:

Author:

Waddell Tom Henry¹^ORCID,Namburete Ana I.L²^ORCID,Duckworth Paul³^ORCID,Cuthbertson Dan⁴^ORCID,Mccracken Celeste⁵^ORCID,Brady Michael⁶^ORCID

Affiliation:

1. Department of Engineering Science, University of Oxford, UK and Perspectum Ltd, UK

2. Department of Computer Science, University of Oxford, UK

3. Oxford Robotics Institute, University of Oxford, UK

4. University of Liverpool, UK

5. Radcliffe Department of Medicine, University of Oxford, UK

6. Perspectum Ltd, UK

Publisher

ACM

Link

https://dl.acm.org/doi/pdf/10.1145/3608298.3608307

Reference19 articles.

1. Digital NHS 2019 , Health survey for England, viewed 10 December 2022 , https://digital.nhs.uk/data-and-information/publications/statistical/health-survey-for-england/2019/main-findings Digital NHS 2019, Health survey for England, viewed 10 December 2022, https://digital.nhs.uk/data-and-information/publications/statistical/health-survey-for-england/2019/main-findings

2. Schnurr T.M. Jakupović H. Carrasquilla G.D. Ängquist L. Grarup N. Sørensen T.I. Tjønneland A. Overvad K. Pedersen O. Hansen T. and Kilpeläinen T.O. 2020. Obesity unfavourable lifestyle and genetic risk of type 2 diabetes: a case-cohort study. Diabetologia 63(7) pp.1324-1332. Schnurr T.M. Jakupović H. Carrasquilla G.D. Ängquist L. Grarup N. Sørensen T.I. Tjønneland A. Overvad K. Pedersen O. Hansen T. and Kilpeläinen T.O. 2020. Obesity unfavourable lifestyle and genetic risk of type 2 diabetes: a case-cohort study. Diabetologia 63(7) pp.1324-1332.

3. Powell-Wiley , T.M. , Poirier , P. , Burke , L.E. , Després , J.P. , Gordon-Larsen , P. , Lavie , C.J. , Lear , S.A. , Ndumele , C.E. , Neeland , I.J. , Sanders , P. and St-Onge , M.P. , 2021. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 143(21), pp.e984-e1010 . Powell-Wiley, T.M., Poirier, P., Burke, L.E., Després, J.P., Gordon-Larsen, P., Lavie, C.J., Lear, S.A., Ndumele, C.E., Neeland, I.J., Sanders, P. and St-Onge, M.P., 2021. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 143(21), pp.e984-e1010.

4. Einarson T.R. Acs A. Ludwig C. and Panton U.H. 2018. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovascular diabetology 17(1) pp.1-19 Einarson T.R. Acs A. Ludwig C. and Panton U.H. 2018. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovascular diabetology 17(1) pp.1-19

5. Cancer Intelligence Team , Cancer Research UK. Overweight and obesity prevalence projections for the UK , England, Scotland, Wales, and Northern Ireland, based on data to 2019/20. Published May 2022 . Cancer Intelligence Team, Cancer Research UK. Overweight and obesity prevalence projections for the UK, England, Scotland, Wales, and Northern Ireland, based on data to 2019/20. Published May 2022.